首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   9379篇
  免费   475篇
  国内免费   45篇
耳鼻咽喉   81篇
儿科学   149篇
妇产科学   76篇
基础医学   1458篇
口腔科学   272篇
临床医学   872篇
内科学   1602篇
皮肤病学   149篇
神经病学   1090篇
特种医学   859篇
外科学   1339篇
综合类   41篇
一般理论   3篇
预防医学   305篇
眼科学   242篇
药学   677篇
中国医学   24篇
肿瘤学   660篇
  2023年   33篇
  2022年   32篇
  2021年   130篇
  2020年   106篇
  2019年   138篇
  2018年   166篇
  2017年   135篇
  2016年   197篇
  2015年   252篇
  2014年   303篇
  2013年   368篇
  2012年   585篇
  2011年   636篇
  2010年   411篇
  2009年   408篇
  2008年   641篇
  2007年   686篇
  2006年   699篇
  2005年   721篇
  2004年   647篇
  2003年   646篇
  2002年   617篇
  2001年   134篇
  2000年   111篇
  1999年   123篇
  1998年   100篇
  1997年   80篇
  1996年   70篇
  1995年   82篇
  1994年   83篇
  1993年   60篇
  1992年   41篇
  1991年   42篇
  1990年   30篇
  1989年   31篇
  1988年   28篇
  1987年   35篇
  1986年   21篇
  1985年   18篇
  1984年   25篇
  1983年   25篇
  1982年   23篇
  1981年   26篇
  1980年   16篇
  1979年   25篇
  1978年   20篇
  1977年   17篇
  1976年   13篇
  1975年   8篇
  1973年   6篇
排序方式: 共有9899条查询结果,搜索用时 140 毫秒
1.
2.
3.
4.
Helicobacter pylori (H. pylori) infection is considered as principal cause of gastric cancer. It is further associated with a reduced risk of esophageal adenocarcinomas. In a large prospective population-based cohort study including 9,949 subjects with average observation time of 13.8 years, we assessed the risk of invasive gastric and esophageal cancer according to H. pylori infection and presence of chronic atrophic gastritis (CAG). Incidence rates and hazard ratios (HR) derived by Cox proportional hazards models and adjusted for relevant confounders were derived by seroprevalence of H. pylori and cytotoxin-associated gene A (CagA) antibodies and presence of CAG based on serological markers at baseline, respectively. During follow-up, 30 cases of noncardia gastric cancer and 33 cases of esophageal cancer were observed. Infection by H. pylori without and with expression of CagA was associated with a 5.2-fold (95% confidence interval 1.00–27.1) and an 18.2-fold (4.3–77.4) increase of noncardia gastric cancer incidence. A 0.65-fold decreased risk of esophageal adenocarcinomas (HR 0.35, 0.12–0.97) was observed among H. pylori-infected individuals. In participants infected with CagA expressed H. pylori, the presence of mild/moderate and severe CAG was associated with a 6.4-fold (1.3–31.0) and an 11.8-fold (3.1–45.4) increase of gastric cancer incidence, respectively. The results of this prospective population-based cohort study may contribute relevant evidence to the ongoing research of H. pylori-related cancers. The results may furthermore enhance the empirical basis for risk stratification among H. pylori-infected people and for recommendations regarding H. pylori screening and treatment among older adults in a Western population.  相似文献   
5.
Evidence on survival of malignant mesothelioma (MM) and other rare thoracic cancers is limited due to the rarity of these cancer sites. Here, we provide a comprehensive overview of MM incidence and survival after MM and other rare thoracic cancers in Germany and the United States (US). Incidence was estimated from a German National Cancer Database and from the Surveillance, Epidemiology and End Results (SEER) 18 database for 2000–2014. Patients diagnosed in 1997–2013 with malignant epithelial tumors of the trachea (Etra), epithelial tumors of the thymus (Ethy) and MM were extracted from a German cancer survival database and from the SEER 13 database. Period analysis was employed to compute 5-year relative survival (RS). During 2000–2014, an annual average of 0.9 and 0.6 MM cases per 100,000 person-years was diagnosed in Germany and the US. Rates decreased in Germany and in the US. Patients with Ethy had highest 5-year RS with US patients surviving longer (69.1% compared to 63.7%, p = 0.02). Survival after Etra was comparable in both countries (Germany 33.6%, US 34.4%, p = 0.07). Survival in MM patients was poor overall (Germany 11.8%, US 12.1%, p < 0.01). Survival improvements were only observed in MM patients in Germany (10.8% [2002–2007] vs. 13.0% [2008–2013], p < 0.01). The lack of progress in survival for Etra and Ethy patients underlines the need of novel preventive, therapeutic and diagnostic approaches. MM incidence significantly decreased in Germany and in the US. Further monitoring of MM incidence is warranted given that a peak in incidence is expected in 2020–2030 in Western countries.  相似文献   
6.
European Archives of Oto-Rhino-Laryngology - Debate on the extent of treatment of neck metastasis of cancer of unknown primary tumors (CUPs) is still ongoing. In two Dutch tertiary referral...  相似文献   
7.
8.
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号